ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:ILU - US4523271090 - Common Stock
114.54 EUR
-2.84 (-2.42%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 21 industry peers in the Life Sciences Tools & Services industry. ILU has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILU has a decent growth rate and is not valued too expensively. This makes ILU very considerable for quality investing!
1. Profitability
1.1 Basic Checks
ILU had positive earnings in the past year.
ILU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ILU reported negative net income in multiple years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of ILU (11.38%) is better than 95.24% of its industry peers.
ILU's Return On Equity of 29.53% is amongst the best of the industry. ILU outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 14.61%, ILU belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROIC | 14.61% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ILU has a Profit Margin of 16.39%. This is amongst the best in the industry. ILU outperforms 85.71% of its industry peers.
ILU has a Operating Margin of 20.41%. This is amongst the best in the industry. ILU outperforms 90.48% of its industry peers.
ILU's Operating Margin has declined in the last couple of years.
ILU has a Gross Margin of 66.74%. This is amongst the best in the industry. ILU outperforms 95.24% of its industry peers.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
ILU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ILU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ILU has more shares outstanding
Compared to 1 year ago, ILU has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.42 indicates that ILU is not in any danger for bankruptcy at the moment.
ILU has a Altman-Z score of 4.42. This is in the better half of the industry: ILU outperforms 76.19% of its industry peers.
ILU has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
ILU has a better Debt to FCF ratio (1.99) than 95.24% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that ILU is not too dependend on debt financing.
ILU has a better Debt to Equity ratio (0.42) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Altman-Z | 4.42 |
ROIC/WACC1.38
WACC10.6%
2.3 Liquidity
ILU has a Current Ratio of 1.43. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
ILU has a Current ratio (1.43) which is comparable to the rest of the industry.
A Quick Ratio of 1.12 indicates that ILU should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, ILU is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 152.02% over the past year.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
ILU shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
The Earnings Per Share is expected to grow by 24.49% on average over the next years. This is a very strong growth
ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.93% yearly.
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 30.96, ILU can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as ILU.
The average S&P500 Price/Earnings ratio is at 26.59. ILU is around the same levels.
A Price/Forward Earnings ratio of 26.45 indicates a quite expensive valuation of ILU.
The rest of the industry has a similar Price/Forward Earnings ratio as ILU.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.03, ILU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.96 | ||
| Fwd PE | 26.45 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ILU is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.63 | ||
| EV/EBITDA | 18.36 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ILU may justify a higher PE ratio.
ILU's earnings are expected to grow with 33.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y44.34%
EPS Next 3Y33.86%
5. Dividend
5.1 Amount
ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:ILU (12/23/2025, 7:00:00 PM)
114.54
-2.84 (-2.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.82%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap17.50B
Revenue(TTM)4.29B
Net Income(TTM)703.00M
Analysts72.86
Price Target105.63 (-7.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.9%
Min EPS beat(2)12.52%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)5.34%
Min EPS beat(4)-7.76%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)97.15%
EPS beat(12)10
Avg EPS beat(12)231.96%
EPS beat(16)13
Avg EPS beat(16)178.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.74%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-0.66%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.29%
Revenue beat(12)4
Avg Revenue beat(12)-0.57%
Revenue beat(16)5
Avg Revenue beat(16)-0.78%
PT rev (1m)8.24%
PT rev (3m)11.41%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)1.32%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.96 | ||
| Fwd PE | 26.45 | ||
| P/S | 4.81 | ||
| P/FCF | 20.63 | ||
| P/OCF | 18.39 | ||
| P/B | 8.66 | ||
| P/tB | 19.78 | ||
| EV/EBITDA | 18.36 |
EPS(TTM)3.7
EY3.23%
EPS(NY)4.33
Fwd EY3.78%
FCF(TTM)5.55
FCFY4.85%
OCF(TTM)6.23
OCFY5.44%
SpS23.81
BVpS13.22
TBVpS5.79
PEG (NY)0.32
PEG (5Y)N/A
Graham Number33.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.38% | ||
| ROE | 29.53% | ||
| ROCE | 20.76% | ||
| ROIC | 14.61% | ||
| ROICexc | 20.97% | ||
| ROICexgc | 38.52% | ||
| OM | 20.41% | ||
| PM (TTM) | 16.39% | ||
| GM | 66.74% | ||
| FCFM | 23.32% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score7
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.42 | ||
| Debt/FCF | 1.99 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 44.36% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.57% | ||
| Profit Quality | 142.25% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 4.42 |
F-Score7
WACC10.6%
ROIC/WACC1.38
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y96.04%
EPS Next 2Y44.34%
EPS Next 3Y33.86%
EPS Next 5Y24.49%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-0.86%
Revenue Next 2Y0.6%
Revenue Next 3Y2.25%
Revenue Next 5Y3.93%
EBIT growth 1Y154.36%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year35.78%
EBIT Next 3Y17.09%
EBIT Next 5Y16.22%
FCF growth 1Y495.24%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y179.8%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILU.DE) is 30.96 and the Price/Book (PB) ratio is 8.66.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILU.DE) is expected to grow by 96.04% in the next year.